The notices it replaced
- Reissues: PAR-21-334 Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)
Who won it before
10 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $8,409,368 in first-year total cost, median $818,975.
Most frequent study sections
- Special Emphasis Panel[ZCA1 RPRB-8 (M2)]6
- Special Emphasis Panel[ZCA1 RPRB-T (J2)]2
- Special Emphasis Panel[ZCA1 SRB-K (J1)]2
Most frequent institutions
- JOHNS HOPKINS UNIVERSITY2
- BECKMAN RESEARCH INSTITUTE/CITY OF HOPE1
- DANA-FARBER CANCER INST1
- MAYO CLINIC ROCHESTER1
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | Using microvolumetric cyst fluid proteolysis for early detection of pancreatic cancer1U01CA282269-01A1 · under PAR-21-334 | KIRKWOOD, KIMBERLY SAUNDERS | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $812,450 | ZCA1 |
| 2024 | Circulating Biomarkers and Imaging for Early Detection of Pancreatic Cancer2U01CA214263-06 · under PAR-21-334 | KILLARY, ANN MKOAY, EUGENE JSEN, SUBRATA | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $799,728 | ZCA1 |
| 2023 | Exosome-based microRNA biomarkers for Non-invasive and Early Detection of Pancreatic Cancer2U01CA214254-06 · under PAR-21-334 | GOEL, AJAYVON HOFF, DANIEL D | BECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA | $923,881 | ZCA1 |
| 2023 | Biomarker Validation in Pancreatic Cystic Neoplasms1U01CA282272-01 · under PAR-21-334 | SIMEONE, DIANE MTSIRIGOS, ARISTOTELIS | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $898,256 | ZCA1 |
| 2023 | Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesions1U01CA274514-01A1 · under PAR-21-334 | BRAND, RANDALLCHAN, DANIEL WANYUIZHANG, HUIZHANG, ZHEN | JOHNS HOPKINS UNIVERSITY, MD | $825,499 | ZCA1 |
| 2023 | Validation of novel imaging and molecular tests for early detection of pancreatic cancer through risk-stratified community engagement programs1U01CA278923-01 · under PAR-21-334 | COTE, GREGORY AGUIMARAES, ALEXANDER SAVIO RAMOSSEARS, ROSALIE CSHEPPARD, BRETT C | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $766,920 | ZCA1 |
| 2022 | Altered metabolism and machine learning for pancreatic cancer early detection2U01CA210171-06 · under PAR-21-334 | ROSENTHAL, MICHAEL H.WOLPIN, BRIAN MATTHEW | DANA-FARBER CANCER INST, MA | $925,639 | ZCA1 |
| 2022 | Pancreatic Cancer Detection Consortium2U01CA210240-06 · under PAR-21-334 | HOLLINGSWORTH, MICHAEL A. | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $857,987 | ZCA1 |
| 2022 | Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer2U01CA210138-06 · under PAR-21-334 | MAJUMDER, SHOUNAKZARET, KENNETH | MAYO CLINIC ROCHESTER, MN | $812,380 | ZCA1 |
| 2022 | Using markers to improve pancreatic cancer screening and surveillance: a multi-center study2U01CA210170-06 · under PAR-21-334 | GOGGINS, MICHAEL G. | JOHNS HOPKINS UNIVERSITY, MD | $786,628 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.